GGrantIndex
Sort

64,565 grants matching drug discovery

Defining the targets of broad intervention antimalarial agents

$652,347
Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2015 · AI

Marfan Aortic Embryologic Origin Influences Aneurysm Formation

$652,347
Michael Peter Fischbein · Stanford University · R01 · FY2025 · HL

Mixed NOP/mu Compounds and the Involvement of Their Receptors in Analgesia

$652,346
Lawrence R Toll · Torrey Pines Inst For Molecular Studies · R01 · FY2017 · DA

Microtubule Regulation

$652,315
Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R01 · FY2010 · GM

Operation and Maintenance of the Biological Data and Processing System

$652,309
Yohaness Teklu · Addis, Inc. · N02 · FY2009 · CA

Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer

$652,287
Daniel J. Powell · University Of Pennsylvania · R01 · FY2023 · CA

Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial

$652,262
Jose Carlos Florez · Massachusetts General Hospital · R01 · FY2022 · DK

CAREER: Random Neural Nets and Random Matrix Products

$652,242
Boris L Hanin · Princeton University · · FY2022 · MPS

UK Spinal Cord & Brain Injury Research Center Core Grant

$652,194
Edward D Hall · University Of Kentucky · P30 · FY2014 · NS

Identification of therapeutic targets for leukemia stem cells in AML-iPSC models

$652,184
Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA

Integrated Platform for Discovery and Validation of Probes that Restore Protein Expression in Single-Gene Causes of Autism and Related Disorders

$652,164
Gavin R Rumbaugh · Scripps Florida · R01 · FY2021 · MH

Skeletal muscle protein structural dynamics and function drive applications to drug discovery

$652,155
David Dale Thomas · University Of Minnesota · R01 · FY2023 · AR

MicroRNA Control of Dilated Cardiomyopathy

$652,134
Mark Mercola · Stanford University · R01 · FY2025 · HL

Genomic Background of Blood Pressure Response to Thiazide Diuretic in African Americans

$652,109
Marguerite R Irvin · University Of Alabama At Birmingham · R01 · FY2020 · HL

Development of Novel Inhibitors of Ganglioside Biosynthesis

$652,045
Brett E Crawford · Zacharon Pharmaceuticals, Inc. · R44 · FY2009 · CA

Melanocortin Receptor Selective Ligands

$651,997
Carrie Haskell-Luevano · University Of Minnesota · R01 · FY2023 · DK

Towards Therapeutics for Neurodegenerative Diseases

$651,920
Stanley B Prusiner · University Of California, San Francisco · R37 · FY2016 · AG

Novel Biguanides to Treat Type 2 Diabetes

$651,885
Ken W Batchelor · Novatarg, Inc. · R44 · FY2015 · DK

CRISPR Genome-Wide sgRNA Library Screening Platform

$651,831
Donato Tedesco · Cellecta, Inc. · R44 · FY2017 · HG

Role of Host Protein Kinase C in Cryptosporidiosis

$651,691
Chelsea S. Marie · University Of Virginia · R01 · FY2024 · AI

Synthetic environmental peptide libraries as a source of novel antibiotics

$651,550
Sean F Brady · Hackensack University Medical Center · U19 · FY2023 · AI

Host determinants of protection against tuberculosis in adolescents

$651,532
Thomas Jens Scriba · University Of Cape Town · R01 · FY2014 · AI

Renal endothelium and the development of chronic kidney disease in sickle cell disorders

$651,479
Samit Ghosh · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK

Discovery/Development of GABA-A α5 Positive Allosteric Modulators for Treatment of MCI due to AD

$651,428
Sharon Rosenzweig-Lipson · Agenebio, Inc. · UH2 · FY2017 · NS

Discovery and Analysis of Synthetic TLR Agonists and Antagonists

$651,422
Dale L Boger · Scripps Research Institute, The · U24 · FY2012 · AI